News

The acquisition expands AMRI’s portfolio of development and large scale manufacturing facilities as well as its customer portfolio, with little overlap of customers between the two companies. The

Roche’s investigational AmpliChip p53 Test is designed to detect damage to p53 DNA in tumor cells in order to identify which cells carry dysfunctional p53 proteins that can

Conny Bogentoft, CEO of Karolinska Development, said: “Aprea is developing a new class of anticancer drugs for the treatment of acute myelogenous leukemia, the most common acute leukemia

The alliance aims to discover and develop antibody therapeutics based on novel modes of action in bone and joint diseases, including rheumatoid arthritis, osteoporosis and osteoarthritis. As part

The two products are intended for the relief of different symptoms and contain different active ingredients. Maalox Total Relief is an upset stomach reliever and anti-diarrheal medication, while

Roche’s investigational AmpliChip p53 Test is designed to detect damage to p53 DNA in tumor cells in order to identify which cells carry dysfunctional p53 proteins that can

Sodium oxybate is the sodium salt form of gamma-hydroxybutyrate, an endogenous neurotransmitter and metabolite of GABA. Reportedly, based on a standard 10-month review, the target date for the

As per the amended agreement, Biogen Idec is expected to assume full development responsibilities and costs, as well as manufacturing rights for the rFVIIIFc and rFIXFc programs. Biogen

Sanofi-aventis said that the aim of the research partnership with Aviesan is to enhance scientific knowledge in the areas of life sciences and healthcare, to develop projects benefiting